Proteomic analysis of carbonylated proteins in the monkey substantia nigra after ischemia-reperfusion

Free Radical Research

Volumn 48, Issue 6, 2014, Pages 694-705

  Oikawa, Shinji ^a   Kobayashi, Hatasu ^a,d   Kitamura, Yuki ^a   Zhu, Hong ^b   Obata, Kumi ^a   Minabe, Yoshio ^b   Dazortsava, Maryia ^b   Ohashi, Kyoko ^a   Tada Oikawa, Saeko ^a   Takahashi, Hitoshi ^c   Yata, Kenichiro ^a   Murata, Mariko ^a   Yamashima, Tetsumori ^b  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbonylated protein; Oxidative stress; Parkinson's disease; Proteomics; Substantia nigra

Indexed keywords

ACONITATE HYDRATASE; ARGININE; ASPARTATE AMMONIA LYASE; CARBONYLATED PROTEIN; CHAPERONE; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; DIHYDROLIPOAMIDE DEHYDROGENASE; FRUCTOSE BISPHOSPHATE ALDOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE C; GLUTAMATE DEHYDROGENASE; GLUTAMATE DEHYDROGENASE 1; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70.1; PROTEIN DERIVATIVE; REACTIVE OXYGEN METABOLITE; T COMPLEX PROTEIN 1 SUBUNIT ALPHA; UNCLASSIFIED DRUG; HEAT-SHOCK PROTEIN 70.1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HIPPOCAMPAL CA1 REGION; IMMUNOCHEMISTRY; LYSOSOME MEMBRANE; MACACA; MEMBRANE STABILIZATION; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN MODIFICATION; PROTEOMICS; REPERFUSION INJURY; SUBSTANTIA NIGRA; TWO DIMENSIONAL ELECTROPHORESIS; ANIMAL; APOPTOSIS; CYTOLOGY; ENZYMOLOGY; LYSOSOME; METABOLISM; MITOCHONDRION; PATHOLOGY; PROTEIN CARBONYLATION;

ANIMALS; APOPTOSIS; DOPAMINERGIC NEURONS; HSP70 HEAT-SHOCK PROTEINS; LYSOSOMES; MACACA; MITOCHONDRIA; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN CARBONYLATION; PROTEOMICS; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; SUBSTANTIA NIGRA;

EID: 84899934920     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.901509     Document Type: Article

References (56)

1. Chen X, Wu G, Schwarzschild MA. Urate in Parkinson's disease: more than a biomarker? Curr Neurol Neurosci Rep 2012;12:367-375.
2. Miller RL, James-Kracke M, Sun GY, Sun AY. Oxidative and infl ammatory pathways in Parkinson's disease. Neurochem Res 2009;34:55-65.
3. Collier TJ, Kanaan NM, Kordower JH. Ageing as a primary risk factor for Parkinson's disease: evidence from studies of non-human primates. Nature reviews. Neuroscience 2011; 12:359-366.
4. Mariani E, Polidori MC, Cherubini A, Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Scie 2005;827:65-75.
5. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993;262:689-695.
6. Nakabeppu Y, Tsuchimoto D, Furuichi M, Sakumi K. The defense mechanisms in mammalian cells against oxidative damage in nucleic acids and their involvement in the suppression of mutagenesis and cell death. Free Radical Res 2004;38:423-429.
7. Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 2004;10:S18-S25.
8. Avery SV. Molecular targets of oxidative stress. Biochem J 2011;434:201-210.
9. Maisonneuve E, Ducret A, Khoueiry P, Lignon S, Longhi S, Talla E, Dukan S. Rules governing selective protein carbonyla-tion. PloS One 2009;4:e7269.
10. Alam ZI, Daniel SE, Lees AJ, Marsden DC, Jenner P, Halliwell B. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997;69:1326-1329.
11. Yamashima T, Kohda Y, Tsuchiya K, Ueno T, Yamashita J, Yoshioka T, Kominami E. Inhibition of ischaemic hippocam-pal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 1998;10: 1723-1733.
12. 2+, PIP2 and calpain responses prior to delayed neuronal death in monkeys. Eur J Neurosci 1996;8:1932-1944.
13. Lehtinen MK, Bonni A. Modeling oxidative stress in the central nervous system. CurrMol Med 2006;6:871-881.
14. Oikawa S, Yamada T, Minohata T, Kobayashi H, Furukawa A, Tada-Oikawa S, et al. Proteomic identifi cation of carbonylated proteins in the monkey hippocampus after ischemia-reperfusion. Free Radic Biol Med 2009;46: 1472-1477.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
16. Nakamura A, Goto S. Analysis of protein carbonyls with 2, 4-dinitrophenyl hydrazine and its antibodies by immunoblot in two-dimensional gel electrophoresis. J Biochem 1996; 119:768-774.
17. Kondo T, Hirohashi S. Application of highly sensitive fl uorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional diff erence gel electrophoresis (2D-DIGE) for cancer proteomics. Nat Protoc 2006;1: 2940-2956.
18. Aksenov MY, Aksenova MV, Butterfield DA, Geddes JW, Markesbery WR. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001;103:373-383.
19. Yata K, Matchett GA, Tsubokawa T, Tang J, Kanamaru K, Zhang JH. Granulocyte-colony stimulating factor inhibits apoptotic neuron loss after neonatal hypoxia-ischemia in rats. Brain Res 2007;1145:227-238.
20. Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol 2006;545:39-50.
21. Mirzaei H, Regnier F. Affi nity chromatographic selection of carbonylated proteins followed by identifi cation of oxidation sites using tandem mass spectrometry. Anal Chem 2005; 77:2386-2392.
22. Wilmarth PA, Tanner S, Dasari S, Nagalla SR Riviere MA, Bafna V, et al. Age-related changes in human crystallins determined from comparative analysis of post-translational mod-ifi cations in young and aged lens: does deamidation contribute to cr ystallin insolubility? J Proteome Res 2006; 5: 2554-2566.
23. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 2004;4:3943-3952.
24. Diedrich M, Mao L, Bernreuther C, Zabel C, Nebrich G, Kleene R, Klose J. Proteome analysis of ventral midbrain in MPTP-treated normal and L1cam transgenic mice. Proteomics 2008;8:1266-1275.
25. Jin J, Meredith GE, Chen L, Zhou Y, Xu J, Shie FS, et al. Quantitative proteomic analysis of mitochondrial proteins: relevance to Lewy body formation and Parkinson's disease. Brain Res Mol Brain Res 2005;134:119-138.
26. Periquet M, Corti O, Jacquier S, Brice A. Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 2005;95:1259-1276.
27. 2-mediated neurotoxicity in rat primary mesencephalic cultures. PloS One 2009;4:e7095.
28. Drechsel DA, Patel M. Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease. Free Radic Biol Med 2008;44:1873-1886.
29. Gille G, Reichmann H. Iron-dependent functions of mitochondria-relation to neurodegeneration. J Neural Transm 2011;118:349-359.
30. Patel M. Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med 2004;37:1951-1962.
31. Butterfi eld DA. Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain. Brain Res 2004; 1000: 1-7.
32. Choi J, Forster MJ, McDonald SR, Weintraub ST, Carroll CA, Gracy RW. Proteomic identifi cation of specifi c oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease. Free Radic Biol Med 2004;36:1155-1162.
33. Castegna A, Aksenov M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, et al. Proteomic identifi cation of oxida-tively modifi ed proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 2002;82:1524-1532.
34. Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 1987;8:521-545.
35. Gomez-Puertas P, Martin-Benito J, Carrascosa JL, Willison KR, Valpuesta JM. The substrate recognition mechanisms in chaperonins. J Mol Recognit 2004;17:85-94.
36. Liu X, Lin CY, Lei M, Yan S, Zhou T, Er ikson RL. CCT chaperonin complex is required for the biogenesis of functional Plk1. Mol Cell Biol 2005;25:4993-5010.
37. Schuller E, Gulesserian T, Seidl R, Cairns N, Lube G. Brain t-complex polypeptide 1 (TCP-1) related to its natural substrate beta1 tubulin is decreased in Alzheimer's disease. Life Sci 2001;69:263-270.
38. Yoo BC, Vlkolinsky R, Engidawork E, Cairns N, Fountoulakis M, Lubec G. Diff erential expression of molecular chaperones in brain of patients with Down syndrome. Electrophoresis 2001;22:1233-1241.
39. Kodavanti PR, Osorio C, Royland JE, Ramabhadran R, Alzate O. Aroclor 1254, a developmental neurotoxicant, alters energy metabolism-And intracellular signaling-Associated protein networks in rat cerebellum and hippocampus. Toxicol Appl Pharmacol 2011;256:290-299.
40. Sullivan PG, Brown MR. Mitochondrial aging and dysfunction in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:407-410.
41. Korotchkina LG, Yang H, Tirosh O, Packer L, Patel MS. Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal. Free Radic Biol Med 2001;30:992-999.
42. Frigerio F, Casimir M, Carobbio S, Maechler P. Tissue spe-cifi city of mitochondrial glutamate pathways and the control of metabolic homeostasis. Biochim Biophys Acta 2008; 1777:965-972.
43. Lai X, Wang J, Nabar NR, Pan S, Tang C, Huang Y, et al. Proteomic response to acupuncture treatment in spontaneously hypertensive rats. PloS One 2012;7:e44216.
44. Michaelis EK, Wang X, Pal R, Bao X, Hascup KN, Wang Y, et al. Neuronal Glud1 (glutamate dehydrogenase 1) over-expressing mice: increased glutamate formation and synaptic release, loss of synaptic activity, and adaptive changes in genomic expression. Neurochem Int 2011;59:473-481.
45. Opii WO, Joshi G, Head E, Milgram NW, Muggenburg BA, Klein JB, et al. Proteomic identifi cation of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease. Neurobiol Aging 2008;29:51-70.
46. Buono P, D'Armiento FP, Terzi G, Alfieri A, Salvatore F. Diff erential distribution of aldolase A and C in the human central nervous system. J Neurocytol 2001;30:957-965.
47. McKenna MC, Hopkins IB, Lindauer SL, Bamford P. Aspartate aminotransferase in synaptic and nonsynaptic mitochondria: diff erential eff ect of compounds that infl uence transient hetero-enzyme complex (metabolon) formation. Neurochem Int 2006;48:629-636.
48. Chang TC, Hsiao CD, Wu SJ, Wang C. The eff ect of mutating arginine-469 on the substrate binding and refolding activities of 70-kDa heat shock cognate protein. Arch Biochem Biophys 2001;386:30-36.
49. Sahara S, Yamashima T. Calpain-mediated Hsp70.1 cleavage in hippocampal CA1 neuronal death. Biochem Biophys Res Commun 2010;393:806-811.
50. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, et al. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apopto-some. Nat Cell Biol 2000;2:469-475.
51. Saleh A, Srinivasula SM, Balkir L, Robbins PD, Alnemri ES. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol 2000;2:476-483.
52. Kirkegaard T, Roth AG, Petersen NH, Mahalka AK, Olsen OD, Moilanen I, et al. Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-Associated lysosomal pathology. Nature 2010;463:549-553.
53. Nylandsted J, Gyrd-Hansen M, Danielewicz A, Fehrenbacher N, Lademann U, Hoyer-Hansen M, et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 2004;200:425-435.
54. Zhu H, Yoshimoto T, Imajo-Ohmi S, Dazortsava M, Mathivanan A, Yamashima T. Why are hippocampal CA1 neurons vulnerable but motor cortex neurons resistant to transient ischemia? J Neurochem 2012;120:574-585.
55. Yamashima T. Hsp70.1 and related lysosomal factors for necrotic neuronal death. J Neurochem 2012;120:477-494.
56. Yamashima T, Oikawa S. The role of lysosomal rupture in neuronal death. Prog Neurobiol 2009;89:343-358.